ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.9 USD
3.59%
Market Closed
Updated:
May 5, 2024
ADC Therapeutics SA
EPS (Diluted)
|
ADC Therapeutics SA
EPS (Diluted) Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
EPS (Diluted)
-$2
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
EPS (Diluted)
-$1
|
CAGR 3-Years
28%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
EPS (Diluted)
-CHf4
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-108%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
7%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's EPS (Diluted)?
EPS (Diluted)
-2.9
USD
-2.9
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's EPS (Diluted) amounts to -2.9 USD.
What is ADC Therapeutics SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-13%
-13%
Over the last year, the EPS (Diluted) growth was -48%. The average annual EPS (Diluted) growth rates for ADC Therapeutics SA have been 3% over the past three years , -13% over the past five years .
You don't have any saved screeners yet
